» Articles » PMID: 23864799

Recent Trends in Hepatitis B Virus Infection in the General Korean Population

Overview
Specialty General Medicine
Date 2013 Jul 19
PMID 23864799
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Hepatitis B virus (HBV) is the major cause of chronic liver disease in Korea, but viral prevalence has decreased because of hepatitis B vaccination programs. In this study, we investigated longitudinal changes in HBV in fection in the general Korean population.

Methods: HBV surface antigen (hepatitis B surface antigen, HBsAg) seropositivity was assessed from the Korea National Health and Nutrition Examination Survey (I to V). In total, 50,140 subjects were tested for serum HBsAg positivity over a period of 12 years (1998 to 2010).

Results: The prevalence of HBsAg seropositivity decreased over the study period. The rates of HBsAg carriers were 4.61% in 1998, 4.60% in 2001, 3.69% in 2005, 3.01% in 2008, and 2.98% in 2010 (p < 0.0001). The reduction in HBV infection rates was more prominent in younger age groups. Among teenagers (10 to 19 years), the percentage of HBsAg carriers decreased from 2.2% in 1998 to 0.12% in 2010 (p < 0.0001). Among those aged 10 to 39 years, the percentage of HBV infection decreased from 4.72% in 1998 to 2.29% in 2010 (p < 0.0001). However, no decreasing trend in HBsAg positivity was observed among those aged 50 or older (p > 0.05). Neither gender nor socioeconomic status were associated with the decreased prevalence of HBsAg carriers.

Conclusions: HBV infection has decreased in the Korean population since the advent of vaccination programs. However, the decrease is limited to the younger population, and viral persistence remains in the middle-aged and older population.

Citing Articles

Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia.

Adugna A, Demeke G, Toru M, Tsehay D, Esmael A, Mihret A PLoS One. 2023; 18(7):e0288355.

PMID: 37418447 PMC: 10328307. DOI: 10.1371/journal.pone.0288355.


Application Effect and Accuracy Analysis of Electrochemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Serological Test of Hepatitis B Virus.

Lian Y, Fu H, Xu X, Ju C Evid Based Complement Alternat Med. 2022; 2022:9371497.

PMID: 35966724 PMC: 9371851. DOI: 10.1155/2022/9371497.


Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea.

Song B, Sinn D, Kang W, Gwak G, Paik Y, Choi M Korean J Intern Med. 2022; 37(5):1082-1087.

PMID: 35569823 PMC: 9449207. DOI: 10.3904/kjim.2021.452.


Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries.

Kang B, Yi D, Choe B Front Pediatr. 2022; 9:809838.

PMID: 35186829 PMC: 8854863. DOI: 10.3389/fped.2021.809838.


Reduced liver cancer mortality with regular clinic follow-up among patients with chronic hepatitis B: A nationwide cohort study.

Shim J, Kim G, Oh C, Kim J, Myung J, Kim B Cancer Med. 2020; 9(20):7781-7791.

PMID: 32857923 PMC: 7571840. DOI: 10.1002/cam4.3421.


References
1.
Lin H, Wang L, Hu C, Huang S, Huang L, Lin S . Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol. 2003; 69(4):471-4. DOI: 10.1002/jmv.10333. View

2.
Manetta T, Gay V, SPREAFICO G, Massaro A, Piantino P . [Instrument applications of three new Bio-Rad kits for HIV, HCV, HBSAG screening: Combo Genscreen Plus HIV 1/2 AG-AB, Monolisa anti HCV Plus V2, Monolisa HBSAG Plus, with the fully authomatic system Plato 3300]. Minerva Med. 2001; 92(5):393-400. View

3.
Jung K, Park S, Kong H, Won Y, Lee J, Seo H . Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012; 44(1):11-24. PMC: 3322196. DOI: 10.4143/crt.2012.44.1.11. View

4.
Vryheid R, Kane M, Muller N, Schatz G, Bezabeh S . Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine. 2001; 19(9-10):1026-37. DOI: 10.1016/s0264-410x(00)00239-5. View

5.
Louisirirotchanakul S, Khupulsup K, Akraekthalin S, Chan K, Saw S, Aw T . Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays. J Med Virol. 2010; 82(5):755-62. DOI: 10.1002/jmv.21706. View